30 completed. 30 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 30 | Completed 30 |
Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Tacrolimus Extended Release Capsule, Mycophenolate mofetil, Prednisone - Immunosuppression | Phase 4 | Completed | Medical University of South Carolina | 25 | 2017-05-05 | 2019-12-26 |
| Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants Everolimus, Mycophenolate mofetil, Tacrolimus - Hypertrophy, Left Ventricular | Phase 4 | Completed | Edoardo Melilli | 20 | 2016-11-01 | 2021-01-08 |
| Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy Astagraf XL, Prograf, Mycophenolate mofetil - End Stage Renal Disease | Phase 4 | Completed | University of Cincinnati | 26 | 2014-05-01 | 2015-05-12 |
| Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients Everolimus, Mycophenolate mofetil, Tacrolimus - Drug Interaction Potentiation | Phase 4 | Completed | National Taiwan University Hospital | 14 | 2014-04-01 | 2019-07-24 |
| Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients Everolimus, Mycophenolic acid dose reduction - BK Virus Infection | Phase 4 | Completed | University of California, San Francisco | 40 | 2012-09-01 | 2016-08-15 |
| A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. Advagraf, Mycophenolate Mofetil, Sirolimus - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 853 | 2011-03-08 | 2024-10-31 |
| A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Advagraf, Mycophenolate Mofetil, Simulect - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 1166 | 2011-01-22 | 2024-11-01 |
| Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV) Mycophenolate to sirolimus switch - Hepatitis C | Phase 4 | Completed | London Health Sciences Centre | 11 | 2010-06-01 | 2015-02-26 |
| Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation mycophenolate mofetil - Acute Rejection of Renal Transplant | Phase 4 | Completed | Nova Scotia Health Authority | 40 | 2010-02-01 | 2012-08-09 |
| A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients MMF, EC-MPS, Prednisone - Kidney Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 23 | 2009-11-01 | 2015-08-27 |
| Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis tacrolimus, tacrolimus and mycophenolate mofetil - Glomerulonephritis, Membranous | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 40 | 2009-03-03 | 2019-12-12 |
| A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients Everolimus (EVR), cyclosporine A (CyA), tacrolimus (TAC) - Heart Transplantation | Phase 4 | Completed | Novartis Pharmaceuticals | 162 | 2009-02-24 | 2018-08-07 |
| A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients. mycophenolate mofetil, tacrolimus, standard dose, tacrolimus, low dose - Kidney Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 210 | 2008-09-01 | 2014-08-04 |
| Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation Basiliximab, Tacrolimus, MMF, Prednisolon, Basiliximab, Tacrolimus, MMF, Tacrolimus, MMF, rATG - Disorder Related to Renal Transplantation | Phase 4 | Completed | University Hospital Freiburg | 600 | 2008-06-01 | 2014-10-01 |
| A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients. Mycophenolate mofetil, CNI (50%), CNI (≥75%) - Liver Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 87 | 2008-05-01 | 2014-09-29 |
| A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients. Mycophenolate mofetil, adjusted dose, Tacrolimus, Corticosteroids, IV - Liver Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 180 | 2007-11-01 | 2014-07-14 |
| Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) Mycophenolate mofetil, sugar pill - Systemic Lupus Erythematosus, Atherosclerosis | Phase 4 | Completed | Guy's and St Thomas' NHS Foundation Trust | 71 | 2006-03-01 | 2011-09-28 |
| Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids basiliximab, MMF/EC-MPS, Corticosteroids - Kidney Transplantation, Adverse Effects | Phase 4 | Completed | Novartis | 7 | 2006-01-01 | 2017-03-29 |
| Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis tacrolimus, mycophenolate mofetil - Lupus Nephritis | Phase 4 | Completed | Tuen Mun Hospital | 150 | 2005-09-01 | 2014-07-02 |
| Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients basiliximab, rabbit anti-thymocyte globulin, tacrolimus - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 501 | 2005-05-01 | 2011-08-11 |
Showing 20 of 30. Sign in to see all of them.
Kidney Failure, Chronic (2) · Acute Kidney Injury (1) · Atherosclerosis (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Glomerulonephritis (1) · Glomerulonephritis, Membranous (1) · Hepatitis C (1) · Hypertrophy, Left Ventricular (1) · Kidney Diseases (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Nephritis (1) · Renal Insufficiency, Chronic (1)
Hoffmann-La Roche (6) · Astellas Pharma Inc (5) · Edoardo Melilli (1) · Erasmus Medical Center (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Imperial College Healthcare NHS Trust (1) · Institute for Clinical and Experimental Medicine (1) · London Health Sciences Centre (1) · Mayo Clinic (1) · Medical University of South Carolina (1) · National Taiwan University Hospital (1) · Nova Scotia Health Authority (1) · Novartis (1) · Novartis Pharmaceuticals (1) · Tuen Mun Hospital (1)
United States (9) · Germany (7) · Spain (5) · Canada (4) · China (4) · France (4) · Australia (3) · Belgium (3) · Czechia (3) · Netherlands (3) · Poland (3) · Switzerland (3) · Taiwan (3) · United Kingdom (3) · Austria (2)
Allison Webber, MD (1) · Bryce A Kiberd, MD (1) · Christian Hugo, Prof. Dr. (1) · David P D'Cruz, MD, FRCP (1) · Edoardo Melilli, MD (1) · Frantisek Saudek, MD (1) · James Fleming, PharmD (1) · Lutz Fricke, MD, PhD (1) · Mark D. Stegall, M.D. (1) · Megan Griffith, MBChB PhD (1)
PMID 39382091, PMID 16468960, PMID 18431244, PMID 18497677, PMID 18946341, PMID 19307792, PMID 19494809, PMID 19714613, PMID 19926370, PMID 20124953, PMID 20670958, PMID 21401720, PMID 23007746, PMID 23423269, PMID 25083614, PMID 25550339, PMID 26465152, PMID 27547871, PMID 27871759, PMID 28342282, PMID 31029086, PMID 31492152, PMID 31561278, PMID 32448782, PMID 34778952, PMID 37391381
2008 (1), 2009 (1)